TITLE

Work, the clinician-scientist and human biochemical genetics

AUTHOR(S)
Scriver, Charles R.
PUB. DATE
August 2001
SOURCE
Clinical & Investigative Medicine;Aug2001, Vol. 24 Issue 4, p179
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mendelian, biochemical and molecular genetics together have revealed what lies behind the 4 canonical inborn errors described by Garrod (albinisn, alkaptonuria, cystinuria and pentosuria). Both older and newer ideas in genetics, new tools for applying them (and renewed respect for the clinician-scientist) will enhance our understanding of the human biological variation that accounts for variant states of health and overt disease. A so-called monogenic phenotype (phenylketonuria) is used to illustrate, in some detail, that all disease phenotypes are, in one way or another, likely to be complex in nature. What can be known and what ought to be done, with knowledge about human genetics, to benefit individuals, families and communities (society), is both opportunity and challenge.
ACCESSION #
5090859

 

Related Articles

  • Metabonomics and medicine: the Biochemical Oracle. Mitchell, Steve; Holmes, elaine; Carmichael, Paul // Biologist;Oct2002, Vol. 49 Issue 5, p217 

    Discusses the opportunities offered by metabonomics to disease processes, drug toxicity and cell function. Information on human genome sequencing; Discussion on nuclear magnetic resonance spectroscopy; Details of the properties and combinations of atoms; Procedures and differences in...

  • Governing Control over Human Genetic Resources: Promises and Risks. Lucchi, Nicola // European Journal of Risk Regulation;2013, Vol. 4 Issue 2, p254 

    The article focuses on the study of biochemical and human genetic material as a part of the market framework. It mentions that biotechnology use living organisms or substances from organisms to modify a product and to develop microorganisms for special purpose. It states that DNA and genetic...

  • Why pharmacogenomics? Why now? Housman, David; Ledley, Fred D. // Nature Biotechnology;Dec98 Supplement 2, Vol. 16, p2 

    Presents the author's ideas on pharmacogenetics. Discovery of genetic variances that affect drug action; Development of new diagnostic procedures; Emergence of managed care as an economic force in medicine.

  • Symbiotic conversations are revealed under genetic interrogation. Ruby, Edward G. // Nature Reviews Microbiology;Oct2008, Vol. 6 Issue 10, p752 

    The recent development and application of molecular genetics to the symbionts of invertebrate animal species have advanced our knowledge of the biochemical communication that occurs between the host and its bacterial symbionts. In particular, the ability to manipulate these associations...

  • Genes and Addictions. Bevilacqua, L.; Goldman, D. // Clinical Pharmacology & Therapeutics;Apr2009, Vol. 85 Issue 4, p359 

    The article examines the genetic aspect of addiction. Addictions are tied together by shared genetic and environmental etiological factors. Craving, binge or intoxication and withdrawal or negative affect are the three phenomena that characterize addiction. It is noted that both genetic and...

  • Cytogenetic and DNA damage on workers exposed to styrene. Teixeira, João Paulo; Gaspar, Jorge; Coelho, Patrícia; Costa, Carla; Pinho-Silva, Susana; Costa, Solange; Da Silva, Susana; Laffon, Blanca; Pásaro, Eduardo; Rueff, José; Farmer, Peter // Mutagenesis;Nov2010, Vol. 25 Issue 6, p617 

    Styrene is a commercially important chemical widely used in the manufacture of synthetic rubber, resins, polyesters and plastics. The highest levels of human exposure to styrene occur during the production of reinforced plastic products. The objective of this work was to evaluate both DNA and...

  • Current Topics.  // WHO Drug Information;2003, Vol. 17 Issue 1, p15 

    Presents news items related to the field of medical care as of January 1, 2003. Survey on direct-to-consumer advertising for prescription drugs; Guidance for industry to recommend categories for collecting effectiveness and safety data during clinical trials; Terminology in pharmacogenetics.

  • Pharmacogenomics: bench to bedside. Weinshilboum, Richard; Liewei Wang // Nature Reviews Drug Discovery;Sep2004, Vol. 3 Issue 9, p739 

    Pharmacogenetics is the study of the role of inheritance in inter-individual variation in drug response. Since its origins in the mid-twentieth century, a major driving force in pharmacogenetics research has been the promise of individualized drug therapy to maximize drug efficacy and minimize...

  • GENETIC TESTING, GENETIC MEDICINE, AND MANAGED CARE. Rothstein, Mark A.; Hoffman, Sharona // Wake Forest Law Review;Fall99, Vol. 34 Issue 3, p849 

    Explores the issues dealing with the impact of human genetics to managed care system. Discussion on the problem of professional education and coverage of genetic services; Examination on the implications of genetics to privacy and confidentiality; Liability aspects of human genetics impact to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics